未找到相关数据
Epirubicin, cyclophosphamide and pyrotinib followed by docetaxel, trastuzumab and pyrotinib as neoadjuvant therapy for stage II-III HER2-positive breast cancer: a single-arm, multicenter phase 2 trial
被引：0
作者：
Shi, Qiyun
Qi, Xiaowei
Tang, Peng
Fan, Linjun
Chen, Li
Wang, Shushu
Zhang, Guozhi
Wang, Mengyuan
Che, Hongying
Lv, Pengwei
Chen, Dejie
Hu, Jinhui
Li, Qiuyun
Zhang, Yanwu
Yu, Qiao
Yang, Kunxian
Zhong, Yuan
Chen, Chuang
Zhou, Zemin
Qian, Liyuan
Zhang, Jingwei
Ma, Mingde
Sun, Yi
Liu, Jiangbo
Zhang, Yi
Jiang, Jun
机构：
关键词：
D O I：
10.1158/1538-7445.SABCS22-OT2-22-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-22-01
引用
收藏
页数：3
相关论文